Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNRNP200 encodes a large RNA helicase that is a core component of the spliceosome complex, essential for pre-mRNA splicing. It catalyzes ATP-dependent unwinding of the U4/U6 RNA duplexes, a crucial step in assembling an active spliceosome. Mutations in SNRNP200 are linked to Retinitis Pigmentosa type 33 (RP33), an autosomal dominant retinal degenerative disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Nuclear Ribonucleoprotein U5 Subunit 200 (SNRNP200).